Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 53
Filtrar
1.
Braz. J. Biol. ; 83: 1-7, 2023. graf
Artículo en Inglés | VETINDEX | ID: vti-765466

RESUMEN

The objective of this study was to evaluate the effectiveness of common antibiotics against different microorganisms in apparently healthy cattle in Shandong province and its suburb. A total of 220 nasal swab samples were collected and cultured for bacteriological evaluation. All the bacteria isolates after preliminary identification were subjected to antibiogram studies following disc diffusion method. It was found in the study that E. coli is the most commonly associated isolate (21%), followed by Klebsiella spp. (18%), Pseudomonas aeruginosa (13%), Salmonella spp. (15%), Shigella spp (12%), and Proteus spp (11%). While the antibiogram studies reveled that highest number of bacterial isolates showed resistance to Ampicillin (95%), followed by Augmentin (91%), Cefuroxime (85%) and Tetracycline (95%) of (Escherichia coli and Klebsiella spp). In the case of pseudomonas spp. and Salmonella the highest resistance was showed by Ampicillin (90%) followed by Amoxicillin + Clavulanic Acid (80%), Cefixime (90%), and Erythromycin (80%). In Shigella spp and Salmonella spp highest resistance was showed by Amoxicillin, Ceftazidime, Augmentin (60%), and Amoxicillin + Clavulanic Acid (50%). It is concluded that in vitro antibiogram studies of bacterial isolates revealed higher resistance for Ampicillin, Augmentin, Cefuroxime, Cefixime, Tetracycline, Erythromycin, and Amoxicillin + Clavulanic Acid. The high multiple Antibiotics resistance indexes (MARI) observed in all the isolates in this study ranging from 0.6 to 0.9. MARI value of >0.2 is suggests multiple antibiotic resistant bacteria and indicate presence of highly resistant bacteria.(AU)


O objetivo deste estudo foi avaliar a eficácia dos antibióticos comuns contra diferentes microrganismos em bovinos aparentemente saudáveis na província de Shandong e seus subúrbios. Um total de 220 amostras de esfregaço nasal foi coletado e cultivado para avaliação bacteriológica. Todos os isolados de bactérias após identificação preliminar foram submetidos a estudos de antibiograma seguindo o método de difusão em disco. Verificou-se no estudo que E. coli é o isolado mais comumente associado (21%), seguido por Klebsiella spp. (18%), Pseudomonas aeruginosa (13%), Salmonella spp. (15%), Shigella spp (12%) e Proteus spp (11%). Enquanto os estudos de antibiograma revelaram que o maior número de isolados bacterianos apresentou resistência à Ampicilina (95%), seguido por Augmentin (91%), Cefuroxima (85%) e Tetraciclina (95%) de (Escherichia coli e Klebsiella spp). No caso de Pseudomonas spp. e Salmonella, a maior resistência foi apresentada pela Ampicilina (90%) seguida pela Amoxicilina + Ácido Clavulânico (80%), Cefixima (90%) e Eritromicina (80%). Em Shigella spp e Salmonella spp, a maior resistência foi demonstrada por Amoxicilina, Ceftazidima, Augmentina (60%) e Amoxicilina + Ácido Clavulânico (50%). Conclui-se que estudos de antibiograma in vitro de isolados bacterianos revelaram maior resistência para Ampicilina, Augmentina, Cefuroxima, Cefixima, Tetraciclina, Eritromicina e Amoxicilina + Ácido Clavulânico. Os altos índices de resistência a antibióticos múltiplos (MARI) observados em todos os isolados neste estudo variaram de 0,6 a 0,9. O valor MARI de > 0,2 sugere várias bactérias resistentes a antibióticos e indica a presença de bactérias altamente resistentes.(AU)


Asunto(s)
Animales , Bovinos , Resistencia a Múltiples Medicamentos , Resistencia betalactámica/efectos de los fármacos , Farmacorresistencia Bacteriana
2.
Braz. j. biol ; 83: 1-7, 2023. graf
Artículo en Inglés | LILACS, VETINDEX | ID: biblio-1468889

RESUMEN

The objective of this study was to evaluate the effectiveness of common antibiotics against different microorganisms in apparently healthy cattle in Shandong province and its suburb. A total of 220 nasal swab samples were collected and cultured for bacteriological evaluation. All the bacteria isolates after preliminary identification were subjected to antibiogram studies following disc diffusion method. It was found in the study that E. coli is the most commonly associated isolate (21%), followed by Klebsiella spp. (18%), Pseudomonas aeruginosa (13%), Salmonella spp. (15%), Shigella spp (12%), and Proteus spp (11%). While the antibiogram studies reveled that highest number of bacterial isolates showed resistance to Ampicillin (95%), followed by Augmentin (91%), Cefuroxime (85%) and Tetracycline (95%) of (Escherichia coli and Klebsiella spp). In the case of pseudomonas spp. and Salmonella the highest resistance was showed by Ampicillin (90%) followed by Amoxicillin + Clavulanic Acid (80%), Cefixime (90%), and Erythromycin (80%). In Shigella spp and Salmonella spp highest resistance was showed by Amoxicillin, Ceftazidime, Augmentin (60%), and Amoxicillin + Clavulanic Acid (50%). It is concluded that in vitro antibiogram studies of bacterial isolates revealed higher resistance for Ampicillin, Augmentin, Cefuroxime, Cefixime, Tetracycline, Erythromycin, and Amoxicillin + Clavulanic Acid. The high multiple Antibiotics resistance indexes (MARI) observed in all the isolates in this study ranging from 0.6 to 0.9. MARI value of >0.2 is suggests multiple antibiotic resistant bacteria and indicate presence of highly resistant bacteria.


O objetivo deste estudo foi avaliar a eficácia dos antibióticos comuns contra diferentes microrganismos em bovinos aparentemente saudáveis na província de Shandong e seus subúrbios. Um total de 220 amostras de esfregaço nasal foi coletado e cultivado para avaliação bacteriológica. Todos os isolados de bactérias após identificação preliminar foram submetidos a estudos de antibiograma seguindo o método de difusão em disco. Verificou-se no estudo que E. coli é o isolado mais comumente associado (21%), seguido por Klebsiella spp. (18%), Pseudomonas aeruginosa (13%), Salmonella spp. (15%), Shigella spp (12%) e Proteus spp (11%). Enquanto os estudos de antibiograma revelaram que o maior número de isolados bacterianos apresentou resistência à Ampicilina (95%), seguido por Augmentin (91%), Cefuroxima (85%) e Tetraciclina (95%) de (Escherichia coli e Klebsiella spp). No caso de Pseudomonas spp. e Salmonella, a maior resistência foi apresentada pela Ampicilina (90%) seguida pela Amoxicilina + Ácido Clavulânico (80%), Cefixima (90%) e Eritromicina (80%). Em Shigella spp e Salmonella spp, a maior resistência foi demonstrada por Amoxicilina, Ceftazidima, Augmentina (60%) e Amoxicilina + Ácido Clavulânico (50%). Conclui-se que estudos de antibiograma in vitro de isolados bacterianos revelaram maior resistência para Ampicilina, Augmentina, Cefuroxima, Cefixima, Tetraciclina, Eritromicina e Amoxicilina + Ácido Clavulânico. Os altos índices de resistência a antibióticos múltiplos (MARI) observados em todos os isolados neste estudo variaram de 0,6 a 0,9. O valor MARI de > 0,2 sugere várias bactérias resistentes a antibióticos e indica a presença de bactérias altamente resistentes.


Asunto(s)
Animales , Bovinos , Farmacorresistencia Bacteriana , Resistencia a Múltiples Medicamentos , Resistencia betalactámica/efectos de los fármacos
3.
Rev. cuba. med. trop ; 73(2): e503, 2021. tab, graf
Artículo en Español | LILACS, CUMED | ID: biblio-1347482

RESUMEN

Introdución: Las ß-lactamasas AmpC son enzimas con capacidad hidrolítica, pueden ser de tipo constitutivo o inducible. No existe un método estandarizado para su determinación fenotípica por normas internacionales; la detección de estas mediante el uso de la biología molecular podría ser una alternativa útil para vigilancia y control de la diseminación de clones circulantes en el entorno hospitalario. Objetivo: Determinar el fenotipo de resistencia y genes expresados en la producción de ß-lactamasas AmpC en bacilos gramnegativos de aislados clínicos en un centro hospitalario. Métodos: Estudio observacional, descriptivo y de corte transversal. Se seleccionaron 78 cepas bacterianas como portadoras de ß- lactamasas AmpC. Se les realizó prueba de aproximación de disco; a las cepas con resultado positivo se seleccionaron para extracción de ADN y PCR multiplex para detección de 6 familias genes AmpC. Se determinó la frecuencia por tipo de muestra, servicio y comparación con el perfil de susceptibilidad. Resultados: De las cepas seleccionadas con fenotipo AmpC, el 57,6 por ciento (45/78) se consideró caso confirmado ß-lactamasas AmpC por su positividad para la prueba confirmatoria. La técnica molecular utilizada confirmó en el 40 por ciento (18/45) la presencia de genes AmpC. Se obtuvo con mayor frecuencia el gen MIR n= 9 (20 por ciento), seguido de DHA n= 7 (15 por ciento). Conclusiones: La detección oportuna de genes que codifican para ß-lactamasas AmpC permite establecer estrategias para evitar la circulación mediada por plásmidos en hospitales, así como utilizar mejores opciones terapéuticas que no induzcan a otros mecanismos de resistencia(AU)


Introduction: AmpC ß--lactamases are enzymes with hydrolytic activity. They may be either constitutive or inducible. No standardized method is available for their phenotypical determination by international standards. Their detection by molecular biology could be a useful alternative for the surveillance and control of the spread of clones circulating in hospital environments. Objective: Determine the resistance phenotype and genes expressed in the production of AmpC ß-lactamases in Gram-negative bacilli from clinical isolates in a hospital. Methods: An observational descriptive cross-sectional study was conducted. A total 78 bacterial strains were selected as carriers of AmpC ß-lactamases. Disc approximation tests were performed. The strains testing positive were selected for DNA extraction and multiplex PCR for detection of six AmpC gene families. Determination was made of the frequency per sample type, service and comparison with the susceptibility profile. Results: Of the strains selected with AmpC phenotype, 57.6 percent (45/78) were considered to be AmpC β-lactamase confirmed cases, due to their positive confirmatory test. The molecular technique used confirmed the presence of AmpC genes in 40 percent (18/45) of the cases. The gene most commonly obtained was MIR n= 9 (20 percent), followed by DHA n= 7 (15 percent). Conclusions: Timely detection of genes encoding for AmpC ß-lactamases makes it possible to set up strategies to prevent plasmid-mediated circulation in hospitals, as well as apply better therapeutic options that do not induce other resistance mechanisms(AU)


Asunto(s)
Humanos , Masculino , Femenino , Farmacorresistencia Microbiana/efectos de los fármacos , Resistencia betalactámica/efectos de los fármacos , Reacción en Cadena de la Polimerasa Multiplex , Biología Molecular , Epidemiología Descriptiva , Estudios Transversales , Colombia , Genes/fisiología
4.
Rev. cuba. med. trop ; 72(3): e605, sept.-dic. 2020. graf
Artículo en Español | LILACS, CUMED | ID: biblio-1156539

RESUMEN

Introducción: Escherichia coli extraintestinal constituye uno de los principales patógenos causantes de infecciones asociadas a la asistencia sanitaria con un alto impacto en la salud por su morbilidad y mortalidad. Objetivo: Describir el comportamiento clínico de E. coli extraintestinal en hospitales cubanos, así como determinar la resistencia antimicrobiana y la producción de betalactamasas. Métodos: Se realizó un estudio descriptivo de corte transversal, durante el período de mayo 2017 a junio 2018, en el Laboratorio Nacional de Referencia de Microbiología del Instituto de Medicina Tropical Pedro Kourí que incluyó 119 aislados de Escherichia coli causantes de infecciones extraintestinales en 30 hospitales de diferentes áreas geográficas del país. Se llevó a cabo la identificación mediante el sistema API 20E y la determinación de la susceptibilidad in vitro a 16 antimicrobianos por el sistema automatizado VITEK-2 y el método de difusión por disco, excepto para la colistina que se empleó el método de elución de disco. Se realizó, además, la detección fenotípica de betalactamasa de espectro extendido, de tipo AmpC y metalobetalactamasa. Resultados: E. coli extraintestinal causó con mayor frecuencia infección de herida quirúrgica (23,5 por ciento), infección del torrente sanguíneo (20,7 por ciento), infecciones respiratorias (17,6 por ciento), infecciones de piel (16,8 por ciento) e infección del tracto urinario (12,6 por ciento). Predominó la resistencia a betalactámicos que osciló entre 61,3 por ciento y 89,1 por ciento, mientras que 79,8 por ciento y 80,5 por ciento de los aislados fueron resistentes a trimetoprim/sulfametoxazol y tetraciclina, respectivamente. La amikacina, la fosfomicina, la colistina y los carbapenémicos mostraron mayor actividad in vitro. El 43,7 por ciento produjo betalactamasas de espectro extendido, 7,6 por ciento AmpC plasmídica y 0,8 por ciento metalobetalactamasa. Conclusiones: La escasa sensibilidad en los aislados de E. coli extraintestinal a los antimicrobianos de primera línea, así como la detección de un aislado productor de metalobetalactamasa evidencia la necesidad de mantener un monitoreo continuo de este patógeno para el cual las alternativas de tratamiento son cada vez más restringidas(AU)


Introduction: Extraintestinal Escherichia coli is one of the main pathogens causing infections associated to health care, with a high impact on health, due to its morbidity and mortality. Objective: Describe the clinical behavior of extraintestinal E. coli in Cuban hospitals, and determine antimicrobial resistance and betalactamase production. Methods: A descriptive cross-sectional study was conducted at the Microbiology National Reference Laboratory of Pedro Kourí Tropical Medicine Institute from May 2017 to June 2018. The study included 119 Escherichia coli isolates causing extraintestinal infections in 30 hospitals from various geographic areas in the country. Identification was based on the API 20E system, and determination of in vitro susceptibility to 16 antimicrobials on the automated system VITEK-2 and the disk diffusion method, except for colistin, for which the disk elution method was used. Phenotypical detection was also performed of AmpC extended-spectrum betalactamase and metallobetalactamase. Results: The most common disorders caused by extraintestinal E. coli were surgical wound infection (23.5 percent), bloodstream infection (20.7 percent), respiratory infections (17.6 percent), skin infections (16.8 percent) and urinary tract infection (12.6 percent). A predominance was found of resistance to betalactams, which ranged between 61.3 percent y 89.1 percent, whereas 79.8 percent and 80.5 percent of the isolates were resistant to trimethoprim / sulfamethoxazole and tetracycline, respectively. Amikacin, fosfomycin, colistin and carbapenemics displayed greater in vitro activity. 43.7 percent produced extended spectrum betalactamases, 7.6 percent plasmid AmpC and 0.8 percent metallobetalactamase. Conclusions: The low sensitivity of extraintestinal E. coli isolates to first-line antimicrobials and the detection of a metallobetalactamase producing isolate are evidence of the need to maintain continuous surveillance of this pathogen, for which the treatment options are ever more restricted.


Asunto(s)
Humanos , Resistencia betalactámica/efectos de los fármacos , Antiinfecciosos/uso terapéutico , Epidemiología Descriptiva , Estudios Transversales , Escherichia coli Patógena Extraintestinal/patogenicidad
5.
J Appl Oral Sci ; 26: e20170065, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29489934

RESUMEN

Considering oral diseases, antibiofilm compounds can decrease the accumulation of pathogenic species such as Streptococcus mutans at micro-areas of teeth, dental restorations or implant-supported prostheses. OBJECTIVE: To assess the effect of thirteen different novel lactam-based compounds on the inhibition of S. mutans biofilm formation. MATERIAL AND METHODS: We synthesized compounds based on γ-lactones analogues from rubrolides by a mucochloric acid process and converted them into their corresponding γ-hydroxy-γ-lactams by a reaction with isobutylamine and propylamine. Compounds concentrations ranging from 0.17 up to 87.5 µg mL-1 were tested against S. mutans. We diluted the exponential cultures in TSB and incubated them (37°C) in the presence of different γ-lactones or γ-lactams dilutions. Afterwards, we measured the planktonic growth by optical density at 630 nm and therefore assessed the biofilm density by the crystal violet staining method. RESULTS: Twelve compounds were active against biofilm formation, showing no effect on bacterial viability. Only one compound was inactive against both planktonic and biofilm growth. The highest biofilm inhibition (inhibition rate above 60%) was obtained for two compounds while three other compounds revealed an inhibition rate above 40%. CONCLUSIONS: Twelve of the thirteen compounds revealed effective inhibition of S. mutans biofilm formation, with eight of them showing a specific antibiofilm effect.


Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Lactonas/farmacología , Streptococcus mutans/efectos de los fármacos , beta-Lactamas/farmacología , Análisis de Varianza , Antibacterianos/síntesis química , Biopelículas/crecimiento & desarrollo , Recuento de Colonia Microbiana , Relación Dosis-Respuesta a Droga , Violeta de Genciana , Lactonas/síntesis química , Pruebas de Sensibilidad Microbiana , Viabilidad Microbiana/efectos de los fármacos , Microscopía Electrónica de Rastreo , Plancton/efectos de los fármacos , Plancton/crecimiento & desarrollo , Reproducibilidad de los Resultados , Streptococcus mutans/crecimiento & desarrollo , Resistencia betalactámica/efectos de los fármacos , beta-Lactamas/síntesis química
6.
Braz. j. infect. dis ; Braz. j. infect. dis;22(1): 51-54, Jan.-feb. 2018. tab, graf
Artículo en Inglés | LILACS, Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1039210

RESUMEN

ABSTRACT A retrospective cohort study, were evaluated: polymyxin B plus aminoglycosides or polymyxin B plus other antibiotics. Any degree of acute kidney injury occurred in 26 (86.6%) patients. The median time to acute kidney injury was 6.0 (95% CI 3-14) days in the polymyxin-aminoglycoside containing regimen group, against 27.0 (95% CI 6-42) days in the polymyxin with other antimicrobial combinations group (p = 0.03). Polymyxin B with aminoglycosides group progressed faster to any degree of renal dysfunction.


Asunto(s)
Humanos , Masculino , Femenino , Polimixina B/uso terapéutico , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Riñón/efectos de los fármacos , Mediastinitis/microbiología , Mediastinitis/tratamiento farmacológico , Antibacterianos/uso terapéutico , Pruebas de Sensibilidad Microbiana , Carbapenémicos/farmacología , Estudios Retrospectivos , Resultado del Tratamiento , Estadísticas no Paramétricas , Medición de Riesgo , Resistencia betalactámica/efectos de los fármacos , Infecciones por Enterobacteriaceae/mortalidad , Estimación de Kaplan-Meier , Lesión Renal Aguda/inducido químicamente , Aminoglicósidos/uso terapéutico , Mediastinitis/mortalidad
7.
Braz J Infect Dis ; 22(1): 51-54, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29182906

RESUMEN

A retrospective cohort study, were evaluated: polymyxin B plus aminoglycosides or polymyxin B plus other antibiotics. Any degree of acute kidney injury occurred in 26 (86.6%) patients. The median time to acute kidney injury was 6.0 (95% CI 3-14) days in the polymyxin-aminoglycoside containing regimen group, against 27.0 (95% CI 6-42) days in the polymyxin with other antimicrobial combinations group (p=0.03). Polymyxin B with aminoglycosides group progressed faster to any degree of renal dysfunction.


Asunto(s)
Antibacterianos/uso terapéutico , Infecciones por Enterobacteriaceae/tratamiento farmacológico , Riñón/efectos de los fármacos , Mediastinitis/tratamiento farmacológico , Mediastinitis/microbiología , Polimixina B/uso terapéutico , Lesión Renal Aguda/inducido químicamente , Aminoglicósidos/uso terapéutico , Carbapenémicos/farmacología , Infecciones por Enterobacteriaceae/mortalidad , Femenino , Humanos , Estimación de Kaplan-Meier , Masculino , Mediastinitis/mortalidad , Pruebas de Sensibilidad Microbiana , Estudios Retrospectivos , Medición de Riesgo , Estadísticas no Paramétricas , Resultado del Tratamiento , Resistencia betalactámica/efectos de los fármacos
8.
J. appl. oral sci ; J. appl. oral sci;26: e20170065, 2018. graf
Artículo en Inglés | LILACS, BBO - Odontología | ID: biblio-893689

RESUMEN

Abstract Considering oral diseases, antibiofilm compounds can decrease the accumulation of pathogenic species such as Streptococcus mutans at micro-areas of teeth, dental restorations or implant-supported prostheses. Objective To assess the effect of thirteen different novel lactam-based compounds on the inhibition of S. mutans biofilm formation. Material and methods We synthesized compounds based on γ-lactones analogues from rubrolides by a mucochloric acid process and converted them into their corresponding γ-hydroxy-γ-lactams by a reaction with isobutylamine and propylamine. Compounds concentrations ranging from 0.17 up to 87.5 μg mL-1 were tested against S. mutans. We diluted the exponential cultures in TSB and incubated them (37°C) in the presence of different γ-lactones or γ-lactams dilutions. Afterwards, we measured the planktonic growth by optical density at 630 nm and therefore assessed the biofilm density by the crystal violet staining method. Results Twelve compounds were active against biofilm formation, showing no effect on bacterial viability. Only one compound was inactive against both planktonic and biofilm growth. The highest biofilm inhibition (inhibition rate above 60%) was obtained for two compounds while three other compounds revealed an inhibition rate above 40%. Conclusions Twelve of the thirteen compounds revealed effective inhibition of S. mutans biofilm formation, with eight of them showing a specific antibiofilm effect.


Asunto(s)
Streptococcus mutans/efectos de los fármacos , Biopelículas/efectos de los fármacos , beta-Lactamas/farmacología , Lactonas/farmacología , Antibacterianos/farmacología , Plancton/crecimiento & desarrollo , Plancton/efectos de los fármacos , Streptococcus mutans/crecimiento & desarrollo , Microscopía Electrónica de Rastreo , Recuento de Colonia Microbiana , Pruebas de Sensibilidad Microbiana , Reproducibilidad de los Resultados , Análisis de Varianza , Biopelículas/crecimiento & desarrollo , Resistencia betalactámica/efectos de los fármacos , beta-Lactamas/síntesis química , Relación Dosis-Respuesta a Droga , Viabilidad Microbiana/efectos de los fármacos , Violeta de Genciana , Lactonas/síntesis química , Antibacterianos/síntesis química
9.
Acta Paul. Enferm. (Online) ; 30(6): 651-657, Nov.-Dez. 2017. tab, graf
Artículo en Portugués | BDENF - Enfermería, LILACS | ID: biblio-885911

RESUMEN

Resumo Objetivo: Analisar as evidências científicas disponíveis na literatura sobre os microrganismos que colonizam os trabalhadores de saúde e sua associação com a resistência a antimicrobianos. Métodos: Revisão integrativa de literatura. A busca dos estudos primários foi realizada nas bases de informação: National Library of Medicine National Institutes of Health, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Scopus e Biblioteca virtual em saúde. Os descritores utilizados foram aplicados de acordo com particularidades de cada base de dados e obtidos por consulta nos Descritores de Ciências em Saúde e Medical Subject Headings. Resultados: A revisão foi composta de 14 estudos primários. Na análise das amostras as pesquisas encontraram principalmente Staphylococcus aureus e Staphylococcus aureus resistente a meticilina colonizando os trabalhadores de saúde. A resistência das bactérias à clindamicina e oxacilina apresentaram maior destaque nas amostras. Conclusão: O Staphylococcus aureus foi evidenciado nos estudos como principal bactéria colonizadora dos trabalhadores de saúde. A preocupação é que essas bactérias apresentam grande capacidade de resistência aos antibióticos beta-lactâmicos.


Abstract Objective: To analyze the scientific evidence in the literature on microorganisms that colonize in healthcare workers and the association with antimicrobial resistance. Methods: Integrative review. The search for primary studies was conducted in the following information databases: National Library of Medicine - National Institutes of Health, Cumulative Index to Nursing and Allied Health Literature, Web of Science, Scopus, and Virtual Health Library. The descriptors used were applied according to the particularities of each database and obtained through consulting the Health Sciences Descriptors and Medical Subject Headings. Results: The review was made up of 14 primary studies. In the analysis of the samples, the searches mainly found Staphylococcus aureus and methicillin-resistant Staphylococcus aureus colonizing in healthcare workers. Bacterial resistance to clindamycin and oxacillin was more predominant in the samples. Conclusion: In the studies, Staphylococcus aureus was the main colonizing bacteria in healthcare workers. The concern is that these bacteria have a strong resistance capacity to beta-lactam antibiotics.


Asunto(s)
Humanos , Staphylococcus aureus , Infecciones Bacterianas , Personal de Salud , Resistencia betalactámica/efectos de los fármacos , Farmacorresistencia Bacteriana , Staphylococcus aureus Resistente a Meticilina , Hospitales
10.
Rev Inst Med Trop Sao Paulo ; 59: e70, 2017 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-29116290

RESUMEN

The present study aims to detect the production of extended-spectrum beta-lactamases (ESBL) by enterobacteria isolated from samples of fresh shrimp and fish obtained from the retail trade of the city of Sobral, Ceará State, Brazil. All bacterial isolates were submitted to identification and antimicrobial susceptibility testing using aminopenicillin, beta-lactamase inhibitors, carbapenem, 1st, 2nd, 3rd and 4th generation cephalosporins, and monobactam. Three types of beta-lactamases - ESBL, AmpC and KPC - were investigated. 103 strains were identified, and the most frequent species in shrimp and fish samples was Enterobacter cloacae (n = 54). All the strains were resistant to penicillin and more than 50% of the isolates were resistant to ampicillin and cephalothin. Resistance to three 3rd generation cephalosporins (cefotaxime, ceftriaxone and ceftazidime) and one fourth generation cephalosporin (cefepime) was detected in two isolates of E. cloacae from shrimp samples. Phenotypic detection of AmpC was confirmed in seven strains. The ESBL was detected in two strains of E. cloacae from shrimp samples. No strain showed KPC production. These data can be considered alarming, since food (shrimp and fish) may be carriers of enterobacteria resistant to drugs of clinical interest.


Asunto(s)
Antibacterianos/farmacología , Proteínas Bacterianas/efectos de los fármacos , Enterobacteriaceae/efectos de los fármacos , Peces/microbiología , Microbiología de Alimentos , Palaemonidae/microbiología , Resistencia betalactámica/efectos de los fármacos , beta-Lactamasas/efectos de los fármacos , Animales , Proteínas Bacterianas/biosíntesis , Brasil , Enterobacteriaceae/enzimología , Enterobacteriaceae/aislamiento & purificación , Pruebas de Sensibilidad Microbiana , beta-Lactamasas/biosíntesis
11.
Genet Mol Res ; 15(3)2016 Sep 23.
Artículo en Inglés | MEDLINE | ID: mdl-27706778

RESUMEN

Pseudomonas aeruginosa is one of the most important causes of nosocomial infection and it has increasing resistance to many antimicrobial agents. ß-lactamase production is the most frequent mechanism for ß-lactam resistance in P. aeruginosa. We evaluated the prevalence of ß-lactamase genes in P. aeruginosa for classes A, C, and D by polymerase chain reaction, and investigated clonal diversity by pulsed-field gel electrophoresis (PFGE). We used the disk diffusion method to test 118 non-duplicate clinical isolates of P. aeruginosa for antimicrobial susceptibility. We identified 51 isolates (43.22%) as multidrug-resistant P. aeruginosa, approximately 44.91% of which were resistant to ceftazidime. ß-lactamase genes were found in 80 isolates of P. aeruginosa (67.80%). The genes that encode VEB-1, AmpC, and OXA-10 were detected in 9 (7.62%), 75 (63.56%), and 18 (15.25%) of these isolates, respectively. The genes that encode PER-1, CTX-M, TEM-1 and derivatives, and SHV-1 were not found in any of the P. aeruginosa isolates. We identified 29 different pulsotypes by PFGE. Two predominant pulsotypes were found. In pulsotype 1, OXA- 10, which was co-produced with the AmpC gene, was predominant. Moreover, VEB-1-producing strains were found to be scattered in many pulsotypes, and AmpC-producing strains showed high pulsotype diversity. The prevalence of ß-lactamase genes in P. aeruginosa was represented by the genetic heterogeneity of OXA-10, AmpC, and VEB-1. The predominant clone of P. aeruginosa clinical isolates was OXA-10. This raises concern about oxacillinases among P. aeruginosa clinical isolates.


Asunto(s)
Pseudomonas aeruginosa/enzimología , Pseudomonas aeruginosa/aislamiento & purificación , Centros de Atención Terciaria , beta-Lactamasas/metabolismo , Antibacterianos/farmacología , Electroforesis en Gel de Campo Pulsado , Pruebas de Sensibilidad Microbiana , Filogenia , Reacción en Cadena de la Polimerasa , Pseudomonas aeruginosa/efectos de los fármacos , Tailandia , Resistencia betalactámica/efectos de los fármacos
12.
Mem Inst Oswaldo Cruz ; 111(9): 551-8, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27653359

RESUMEN

Carbapenem-resistance mechanisms are a challenge in the treatment of Pseudomonas aeruginosa infections. We investigated changes in P. aeruginosa carbapenem-resistance determinants over a time period of eight years after the emergence of São Paulo metallo-ß-lactamase in a university hospital in Rio de Janeiro, Brazil. Patients admitted to the intensive care unit (ICU) were screened for P. aeruginosa colonisation and followed for the occurrence of infections from April 2007 to April 2008. The ICU environment was also sampled. Isolates were typed using random amplified polymorphic DNA, pulsed-field gel electrophoresis and multilocus sequence typing. Antimicrobial susceptibility was determined by disk diffusion and E-test, production of carbapenemases by a modified-CarbaNP test and presence of carbapenemase-encoding genes by polymerase chain reaction. Non-carbapenemase resistance mechanisms studied included efflux and AmpC overexpression by PAßN and cloxacillin susceptibility enhancement, respectively, as well as oprD mutations. From 472 P. aeruginosa clinical isolates (93 patients) and 17 isolates from the ICU environment, high genotypic diversity and several international clones were observed; one environment isolate belonged to the blaSPM-1 P. aeruginosa epidemic genotype. Among isolates from infections, 10 (29%) were carbapenem resistant: none produced carbapenemases, three exhibited all non-carbapenemase mechanisms studied, six presented a combination of two mechanisms, and one exclusively displayed oprD mutations. Carbapenem-resistant P. aeruginosa displayed a polyclonal profile after the SPM-1 epidemic genotype declined. This phenomenon is connected with blaSPM-1 P. aeruginosa replaced by other carbapenem-resistant pathogens.


Asunto(s)
Carbapenémicos/farmacología , Infecciones por Pseudomonas/microbiología , Pseudomonas aeruginosa/enzimología , Resistencia betalactámica/genética , beta-Lactamasas/biosíntesis , Antibacterianos/farmacología , ADN Bacteriano/genética , Pruebas Antimicrobianas de Difusión por Disco , Electroforesis en Gel de Campo Pulsado , Genotipo , Hospitales Universitarios , Humanos , Unidades de Cuidados Intensivos , Tipificación de Secuencias Multilocus , Reacción en Cadena de la Polimerasa , Estudios Prospectivos , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética , Resistencia betalactámica/efectos de los fármacos
13.
Mem. Inst. Oswaldo Cruz ; 111(9): 551-558, Sept. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-794722

RESUMEN

Carbapenem-resistance mechanisms are a challenge in the treatment of Pseudomonas aeruginosa infections. We investigated changes in P. aeruginosa carbapenem-resistance determinants over a time period of eight years after the emergence of São Paulo metallo-β-lactamase in a university hospital in Rio de Janeiro, Brazil. Patients admitted to the intensive care unit (ICU) were screened for P. aeruginosa colonisation and followed for the occurrence of infections from April 2007 to April 2008. The ICU environment was also sampled. Isolates were typed using random amplified polymorphic DNA, pulsed-field gel electrophoresis and multilocus sequence typing. Antimicrobial susceptibility was determined by disk diffusion and E-test, production of carbapenemases by a modified-CarbaNP test and presence of carbapenemase-encoding genes by polymerase chain reaction. Non-carbapenemase resistance mechanisms studied included efflux and AmpC overexpression by PAβN and cloxacillin susceptibility enhancement, respectively, as well as oprD mutations. From 472 P. aeruginosa clinical isolates (93 patients) and 17 isolates from the ICU environment, high genotypic diversity and several international clones were observed; one environment isolate belonged to the blaSPM-1 P. aeruginosa epidemic genotype. Among isolates from infections, 10 (29%) were carbapenem resistant: none produced carbapenemases, three exhibited all non-carbapenemase mechanisms studied, six presented a combination of two mechanisms, and one exclusively displayed oprD mutations. Carbapenem-resistant P. aeruginosa displayed a polyclonal profile after the SPM-1 epidemic genotype declined. This phenomenon is connected with blaSPM-1 P. aeruginosa replaced by other carbapenem-resistant pathogens.


Asunto(s)
Humanos , Resistencia betalactámica/genética , beta-Lactamasas/biosíntesis , Carbapenémicos/farmacología , Pseudomonas aeruginosa/enzimología , Infecciones por Pseudomonas/microbiología , Antibacterianos/farmacología , Resistencia betalactámica/efectos de los fármacos , Pruebas Antimicrobianas de Difusión por Disco , ADN Bacteriano/genética , Electroforesis en Gel de Campo Pulsado , Genotipo , Hospitales Universitarios , Unidades de Cuidados Intensivos , Tipificación de Secuencias Multilocus , Reacción en Cadena de la Polimerasa , Estudios Prospectivos , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/genética
14.
Genet Mol Res ; 14(2): 6723-32, 2015 Jun 18.
Artículo en Inglés | MEDLINE | ID: mdl-26125881

RESUMEN

We explored the mechanism of the development from sensitivity to resistance to carbapenem in Pseudomonas aeruginosa. Two P. aeruginosa strains were collected during treatment with carbapenem. Strain homology was investigated using pulsed-field gel electrophoresis. Porin oprD2 expression was analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The minimum inhibitory concentrations (MICs) of imipenem and meropenem with or without MC207110 were determined using the agar dilution method. The expression level of efflux pump mRNA was tested using real-time polymerase chain reaction. Metallo-lactamases (MBLs) were screened using the EDTA-disk synergy test. Genes encoding MBLs were amplified and then analyzed by DNA sequencing. The two treated strains belonged to the same pulsed-field gel electrophoresis type. The SDS-PAGE profile of the P. aeruginosa strains revealed that the 46-kDa membrane protein OprD2 of IMP(R)MEM(R) type strains was lost, whereas OprD2 of 1 IMP(S)MEM(S) strain was normal. With or without MC207110 treatment, the MIC of carbapenem-resistant P. aeruginosa decreased by 4-fold, while the MIC of carbapenem-sensitive P. aeruginosa did not. Compared with the carbapenem-sensitive strain, MexX mRNA expression in the carbapenem-resistant strain increased by 102.5-fold, while the mRNA expression of other efflux pumps did not markedly increase. Neither carbapenem-resistant nor carbapenem-sensitive P. aeruginosa produced MBL. The mechanism of development from sensitivity to resistance of P. aeruginosa to carbapenem during carbapenem treatment is due to porin oprD2 loss and an increased expression level of MexXY-OprM.


Asunto(s)
Antibacterianos/farmacología , Proteínas de la Membrana Bacteriana Externa/genética , Proteínas Bacterianas/genética , Regulación Bacteriana de la Expresión Génica , Proteínas de Transporte de Membrana/genética , Porinas/genética , Pseudomonas aeruginosa/genética , Resistencia betalactámica/genética , Proteínas de la Membrana Bacteriana Externa/agonistas , Proteínas de la Membrana Bacteriana Externa/metabolismo , Proteínas Bacterianas/agonistas , Proteínas Bacterianas/metabolismo , Dipéptidos/farmacología , Combinación de Medicamentos , Electroforesis en Gel de Campo Pulsado , Electroforesis en Gel de Poliacrilamida , Imipenem/farmacología , Proteínas de Transporte de Membrana/agonistas , Proteínas de Transporte de Membrana/metabolismo , Meropenem , Pruebas de Sensibilidad Microbiana , Porinas/deficiencia , Pseudomonas aeruginosa/efectos de los fármacos , Pseudomonas aeruginosa/metabolismo , Tienamicinas/farmacología , Resistencia betalactámica/efectos de los fármacos , beta-Lactamasas/genética , beta-Lactamasas/metabolismo
15.
Rev Inst Med Trop Sao Paulo ; 57(6): 513-4, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27049706

RESUMEN

This cross-sectional study, performed in an oncology hospital in Goiania, aimed to characterize the prevalence of oral colonization and antimicrobial susceptibility of Pseudomonas spp. isolated from the saliva of healthcare workers. Microorganisms were subjected to biochemical tests, susceptibility profile, and phenotypic detection. Of 76 participants colonized with Gram negative bacilli, 12 (15.8%) harbored Pseudomonas spp. Of all isolates, P. aeruginosa (75.0%), P. stutzeri (16.7%), and P. fluorescens (8.3%), were resistant to cefoxitin, and therefore likely to be AmpC producers. The results are clinically relevant and emphasize the importance of surveillance to minimize bacterial dissemination and multiresistance.


Asunto(s)
Instituciones Oncológicas , Personal de Salud/estadística & datos numéricos , Boca/microbiología , Infecciones por Pseudomonas/epidemiología , Pseudomonas/aislamiento & purificación , Antibacterianos/uso terapéutico , Brasil/epidemiología , Cefoxitina/uso terapéutico , Estudios Transversales , Humanos , Pruebas de Sensibilidad Microbiana , Prevalencia , Infecciones por Pseudomonas/prevención & control , Saliva/microbiología , Resistencia betalactámica/efectos de los fármacos
16.
Rev Inst Med Trop Sao Paulo ; 56(4): 333-40, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25076435

RESUMEN

Currently multiresistant Staphylococcus aureus is one common cause of infections with high rates of morbidity and mortality worldwide, which directs scientific endeavors in search for novel antimicrobials. In this study, nine extracts from Bidens pilosa (root, stem, flower and leaves) and Annona crassiflora (rind fruit, stem, leaves, seed and pulp) were obtained with ethanol: water (7:3, v/v) and their in vitro antibacterial activity evaluated through both the agar diffusion and broth microdilution methods against 60 Oxacillin Resistant S. aureus (ORSA) strains and against S. aureus ATCC6538. The extracts from B. pilosa and A. crassiflora inhibited the growth of the ORSA isolates in both methods. Leaves of B. pilosa presented mean of the inhibition zone diameters significantly higher than chlorexidine 0.12% against ORSA, and the extracts were more active against S. aureus ATCC (p < 0.05). Parallel, toxicity testing by using MTT method and phytochemical screening were assessed, and three extracts (B. pilosa, root and leaf, and A. crassiflora, seed) did not evidence toxicity. On the other hand, the cytotoxic concentrations (CC50 and CC90) for other extracts ranged from 2.06 to 10.77 mg/mL. The presence of variable alkaloids, flavonoids, tannins and saponins was observed, even though there was a total absence of anthraquinones. Thus, the extracts from the leaves of B. pilosa revealed good anti-ORSA activity and did not exhibit toxicity.


Asunto(s)
Annona/química , Antibacterianos/farmacología , Bidens/química , Extractos Vegetales/farmacología , Staphylococcus aureus/efectos de los fármacos , Resistencia betalactámica/efectos de los fármacos , Clínicas Odontológicas , Microbiología Ambiental , Pruebas de Sensibilidad Microbiana , Staphylococcus aureus/aislamiento & purificación
17.
Rev Inst Med Trop Sao Paulo ; 56(4): 341-6, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-25076436

RESUMEN

A variety of foods and environmental sources harbor bacteria that are resistant to one or more antimicrobial drugs used in medicine and agriculture. Antibiotic resistance in Escherichia coli is of particular concern because it is the most common Gram-negative pathogen in humans. Hence this study was conducted to determine the antibiotic sensitivity pattern of E. coli isolated from different types of food items collected randomly from twelve localities of Hyderabad, India. A total of 150 samples comprising; vegetable salad, raw egg-surface, raw chicken, unpasteurized milk, and raw meat were processed microbiologically to isolate E. coli and to study their antibiotic susceptibility pattern by the Kirby-Bauer method. The highest percentages of drug resistance in isolates of E. coli were detected from raw chicken (23.3%) followed by vegetable salad (20%), raw meat (13.3%), raw egg-surface (10%) and unpasteurized milk (6.7%). The overall incidence of drug resistant E. coli was 14.7%. A total of six (4%) Extended Spectrum ß-Lactamase (ESBL) producers were detected, two each from vegetable salads and raw chicken, and one each from raw egg-surface and raw meat. Multidrug resistant strains of E. coli are a matter of concern as resistance genes are easily transferable to other strains. Pathogen cycling through food is very common and might pose a potential health risk to the consumer. Therefore, in order to avoid this, good hygienic practices are necessary in the abattoirs to prevent contamination of cattle and poultry products with intestinal content as well as forbidding the use of untreated sewage in irrigating vegetables.


Asunto(s)
Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Microbiología de Alimentos , Animales , Bovinos , Recuento de Colonia Microbiana , Pruebas Antimicrobianas de Difusión por Disco , Farmacorresistencia Bacteriana , Escherichia coli/aislamiento & purificación , India , Resistencia betalactámica/efectos de los fármacos
18.
Rev. Inst. Med. Trop. Säo Paulo ; Rev. Inst. Med. Trop. Säo Paulo;56(4): 333-340, Jul-Aug/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-716414

RESUMEN

Currently multiresistant Staphylococcus aureus is one common cause of infections with high rates of morbidity and mortality worldwide, which directs scientific endeavors in search for novel antimicrobials. In this study, nine extracts from Bidens pilosa (root, stem, flower and leaves) and Annona crassiflora (rind fruit, stem, leaves, seed and pulp) were obtained with ethanol: water (7:3, v/v) and their in vitro antibacterial activity evaluated through both the agar diffusion and broth microdilution methods against 60 Oxacillin Resistant S. aureus (ORSA) strains and against S. aureus ATCC6538. The extracts from B. pilosa and A. crassiflora inhibited the growth of the ORSA isolates in both methods. Leaves of B. pilosa presented mean of the inhibition zone diameters significantly higher than chlorexidine 0.12% against ORSA, and the extracts were more active against S. aureus ATCC (p < 0.05). Parallel, toxicity testing by using MTT method and phytochemical screening were assessed, and three extracts (B. pilosa, root and leaf, and A. crassiflora, seed) did not evidence toxicity. On the other hand, the cytotoxic concentrations (CC50 and CC90) for other extracts ranged from 2.06 to 10.77 mg/mL. The presence of variable alkaloids, flavonoids, tannins and saponins was observed, even though there was a total absence of anthraquinones. Thus, the extracts from the leaves of B. pilosa revealed good anti-ORSA activity and did not exhibit toxicity.


Atualmente Staphylococcus aureus multirresistente é causa comum de infecções com altas taxas de morbidade e mortalidade mundialmente, o que direciona esforços científicos na busca de novos antimicrobianos. Neste estudo, nove extratos de Bidens pilosa (raiz, caule, flor e folhas) e de Annona crassiflora (casca do fruto, caule, folha, semente e polpa) foram obtidos com etanol:água (7:3, v/v) e suas atividades antibacteriana in vitro avaliadas através de difusão em agar e microdiluição em caldo contra 60 cepas de Oxacillin Resistant S. aureus (ORSA) e contra S. aureus ATCC 6538. Os extratos de B. pilosa e A. crassiflora inibiram o crescimento dos isolados ORSA em ambos os métodos. O extrato da folha de B. pilosa apresentou média dos diâmetros dos halos de inibição significativamente maior que a clorexidina 0,12%, contra os isolados ORSA, e os extratos foram mais ativos contra S. aureus ATCC (p < 0,05). Paralelamente, teste de toxicidade pelo método MTT e triagem fitoquímica foram avaliadas, e três extratos (raiz e folha de B. pilosa e semente de A. crassiflora) não apresentaram toxicidade. Por outro lado, as concentrações citotóxicas (CC50 e CC90) para os outros extratos variaram de 2,06 a 10,77 mg/mL. Observou-se variável presença de alcalóides, flavonóides, taninos e saponinas, apesar de total ausência de antraquinonas. Portanto, os extratos das folhas de B. pilosa revelaram boa atividade anti-ORSA e não exibiram toxicidade.


Asunto(s)
Annona/química , Antibacterianos/farmacología , Bidens/química , Extractos Vegetales/farmacología , Staphylococcus aureus/efectos de los fármacos , Resistencia betalactámica/efectos de los fármacos , Clínicas Odontológicas , Microbiología Ambiental , Pruebas de Sensibilidad Microbiana , Staphylococcus aureus/aislamiento & purificación
19.
Rev. Inst. Med. Trop. Säo Paulo ; Rev. Inst. Med. Trop. Säo Paulo;56(4): 341-346, Jul-Aug/2014. tab, graf
Artículo en Inglés | LILACS | ID: lil-716426

RESUMEN

A variety of foods and environmental sources harbor bacteria that are resistant to one or more antimicrobial drugs used in medicine and agriculture. Antibiotic resistance in Escherichia coli is of particular concern because it is the most common Gram-negative pathogen in humans. Hence this study was conducted to determine the antibiotic sensitivity pattern of E. coli isolated from different types of food items collected randomly from twelve localities of Hyderabad, India. A total of 150 samples comprising; vegetable salad, raw egg-surface, raw chicken, unpasteurized milk, and raw meat were processed microbiologically to isolate E. coli and to study their antibiotic susceptibility pattern by the Kirby-Bauer method. The highest percentages of drug resistance in isolates of E. coli were detected from raw chicken (23.3%) followed by vegetable salad (20%), raw meat (13.3%), raw egg-surface (10%) and unpasteurized milk (6.7%). The overall incidence of drug resistant E. coli was 14.7%. A total of six (4%) Extended Spectrum β-Lactamase (ESBL) producers were detected, two each from vegetable salads and raw chicken, and one each from raw egg-surface and raw meat. Multidrug resistant strains of E. coli are a matter of concern as resistance genes are easily transferable to other strains. Pathogen cycling through food is very common and might pose a potential health risk to the consumer. Therefore, in order to avoid this, good hygienic practices are necessary in the abattoirs to prevent contamination of cattle and poultry products with intestinal content as well as forbidding the use of untreated sewage in irrigating vegetables.


Variedade de alimentos e fontes ambientais contem bactérias resistentes a uma ou mais drogas antimicrobianas usadas em medicina e agricultura. Resistência antibiótica pela Escherichia coli é particularmente preocupante porque ela é o patógeno mais comum Gram negativo em humanos. Portanto este estudo foi conduzido para determinar o aspecto de sensibilidade antibiótica da E. coli isolados de diferentes tipos de alimentos obtidos ao acaso de 12 localidades de Hyderabad, India. Um total de 150 amostras compreendendo saladas, vegetais, superfícies de ovos crus, galinhas cruas, leite não pasteurizado e carne crua foram processados microbiologicamente para isolar E. coli e estudar o quadro de sensibilidade antibiótica pelo método de Kirby-Bauer. A maior percentagem de resistência à droga foi isolada de E. coli obtidos de galinha crua (23,3%) seguido de saladas e vegetais (20%), carne crua (13,3%), superfície do ovo cru (10%) e leite não pasteurizado (6,7%). Incidência total de E. coli resistente foi de 14,7%. Um total de seis (4%) Extended Spectrum β-Lactamase (ESBL) produtores foram detectados, dois cada de salada de vegetais e galinha crua e um cada de superfície de ovo cru e carne crua. Espécies resistentes a múltiplas drogas de E. coli são matéria de preocupação uma vez que os genes de resistência podem facilmente ser transferidos para outras linhagens. O ciclo do patógeno é muito comum nos alimentos e pode ser risco potencial para a saúde do consumidor. Portanto, para evitar isto boas práticas de higiene são necessárias nos abatedouros para prevenir a contaminação de gado e aves com conteúdo intestinal assim como proibir o uso de águas de esgoto não tratadas para irrigar vegetais.


Asunto(s)
Animales , Bovinos , Antibacterianos/farmacología , Escherichia coli/efectos de los fármacos , Microbiología de Alimentos , Recuento de Colonia Microbiana , Pruebas Antimicrobianas de Difusión por Disco , Farmacorresistencia Bacteriana , Escherichia coli/aislamiento & purificación , India , Resistencia betalactámica/efectos de los fármacos
20.
Biomedica ; 34 Suppl 1: 114-23, 2014 Apr.
Artículo en Español | MEDLINE | ID: mdl-24968043

RESUMEN

INTRODUCTION: Enterobacter cloacae is a pathogenic microorganism with the ability to produce betalactamase enzymes, which makes them resistant to betalactamic antibiotics. Additionally, the limited activity of enzymatic inhibitors has been identified, and, therefore, the design of new drugs and the promotion of their rational use are the only possibilities to overcome this problem. OBJECTIVE: The aim of this research was to evaluate the effect of dihydroxy-phenyl-propenone on a clinical isolate of E. cloacae , as well as its activity on a betalactamase isolated from this resistant microorganism in order to contribute to the search for new betalactamase inhibitors. MATERIALS AND METHODS: Dihydroxy-phenyl-propenone chalcone was synthesized and evaluated on a clinical isolate of E. cloacae to determine the minimum inhibitory concentration by broth microdilution; once the betalactamase enzyme was purified by affinity chromatography, a spectrophotometric analysis was done to evaluate its kinetic activity. RESULTS: The minimum inhibitory concentration value of dihydroxy-phenyl-propenone on E. cloacae was 35 µg/ml; the recovery percentage of the betalactamase from the microorganism was 31.75% and the kinetic parameters were V max =1.7 x 10 -3 µM/min and K M = 2330 µM, which show an important inhibitory activity. CONCLUSION: Dihydroxy-phenyl-propenone has shown inhibitory activity on betalactamase enzymes and the ability to protect the chemical integrity of betalactamic antibiotics; this synergistic effect turns it into a promising compound in the search for new alternatives to overcome bacterial resistance.


Asunto(s)
Proteínas Bacterianas/antagonistas & inhibidores , Chalconas/farmacología , Enterobacter cloacae/efectos de los fármacos , Penicilinasa/metabolismo , Resistencia betalactámica/efectos de los fármacos , Inhibidores de beta-Lactamasas/farmacología , Ampicilina/farmacología , Proteínas Bacterianas/aislamiento & purificación , Proteínas Bacterianas/metabolismo , Chalconas/síntesis química , Chalconas/química , Cromatografía de Afinidad , Recuento de Colonia Microbiana , Colorimetría , Evaluación Preclínica de Medicamentos , Sinergismo Farmacológico , Enterobacter cloacae/enzimología , Infecciones por Enterobacteriaceae/microbiología , Humanos , Pruebas de Sensibilidad Microbiana , Estructura Molecular , Ácido Penicilánico/análogos & derivados , Ácido Penicilánico/antagonistas & inhibidores , Penicilinasa/aislamiento & purificación , Tazobactam , Inhibidores de beta-Lactamasas/síntesis química , Inhibidores de beta-Lactamasas/química
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA